BGMS Company Profile and Key Details

Our AI price prediction model suggests that Bio Green Med Solution, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 2.0%, with price expected at $1.02 by April 16, 2026, within a range of $0.98 to $1.07 3-Month Outlook: Projected fall of -95.0%, reaching $0.05 by July 01, 2026, with a range of $0.01 to $0.09. 1-Year Outlook: Projected loss of -96.0%, with price at $0.04 by April 02, 2027, within a range of $0.00 to $0.08.

BGMS has shown mixed momentum, gaining 12.54% over the past week and -63.79% over the past quarter, though year-to-date performance is down -1.15%. Short-term trend indicators are bullishly aligned (SMA20 -2.32%, SMA50 -19.45%, SMA200 -84.0%). The stock’s 14-day RSI is 41.58 (neutral), while the ATR of 0.1 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -99.0% below its high and over 35.79% above its low. Average 10-day trading volume of 155.84 thousand shares is significantly above the 3-month average of 97.89 thousand, indicating heightened recent market interest.

Bio Green Med Solution, Inc. (NASDAQ:BGMS) closed at $1.00 USD, gaining $0.01 (1.13%) from the previous close of $0.99. The stock is currently mid-range between its 52-week high and low $0.73 and $100.80. With a market capitalization of about $2.20 million, Bio Green Med Solution, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-0.53). Key stats such as the average daily volume over the past year has been around 97.07 thousand shares, in line with its 52-week average. Headquartered in Kuala Lumpur, None, Bio Green Med Solution, Inc. operates in the Healthcare sector and the Medical - Pharmaceuticals industry. A diversified company operating in both the fire protection and biopharmaceutical industries.

Bio Green Med Solution, Inc. generated EPS of -$84.87 over the past year. Five-year average earnings growth is 57.31%. Bio Green Med Solution, Inc. earnings surprise history is a mixed track record. The quarter that ended November 13, 2025, missed forecasts by -98.18%.

Bio Green Med Solution, Inc. has 2.94 million shares outstanding. The public float is 390.79 thousand shares, elevated short interest at 2.52% of float. This equals 53.61 thousand shares. The short ratio is 0.61 days. FITTERS Diversified Berhad holds 279.25 thousand shares, Kua Khai Loon has 0.00 shares and Ong Yee Lung has 0.00 shares. Over the past six months, insider transactions show net selling. They sold 1.57 million shares across 17 transactions.

Bio Green Med Solution, Inc. (NASDAQ:BGMS) shares are flat -1.15% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Bio Green Med Solution, Inc. trading at a premium to the broader market with a P/E of -1.54. Our AI forecast model points to short-term strength (2.0% over two weeks), a medium-term fall (-95.0% over three months), and a longer-term loss (-96.0% over one year), with expected trading ranges indicating moderate volatility.

Bio Green Med Solution, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.87. This means the shares are trading below this model’s fair value.

Bio Green Med Solution, Inc. trades at a P/E ratio of -1.54, slightly below the S&P 500 average, with a price-to-sales ratio of 2.94 and a price-to-book ratio of 0.68 suggesting the stock is closer to book value. The P/FCF stands at -0.46, also below market averages.